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Gain-of-function mutations in the CACNA1H gene (encoding the
T-type calcium channel CaV3.2) cause autosomal-dominant familial
hyperaldosteronism type IV (FH-IV) and early-onset hypertension
in humans. We used CRISPR/Cas9 to generate Cacna1hM1560V/+
knockin mice as a model of the most common FH-IV mutation,
along with corresponding knockout mice (Cacna1h−/−). Adrenal
morphology of both Cacna1hM1560V/+ and Cacna1h−/− mice was
normal. Cacna1hM1560V/+ mice had elevated aldosterone:renin
ratios (a screening parameter for primary aldosteronism). Their
adrenal Cyp11b2 (aldosterone synthase) expression was increased
and remained elevated on a high-salt diet (relative autonomy,
characteristic of primary aldosteronism), but plasma aldosterone
was only elevated in male animals. The systolic blood pressure of
Cacna1hM1560V/+ mice was 8 mmHg higher than in wild-type litter-
mates and remained elevated on a high-salt diet. Cacna1h−/− mice
had elevated renal Ren1 (renin-1) expression but normal adrenal
Cyp11b2 levels, suggesting that in the absence of CaV3.2, stimula-
tion of the renin-angiotensin system activates alternative calcium
entry pathways to maintain normal aldosterone production. On a
cellular level, Cacna1hM1560V/+ adrenal slices showed increased
baseline and peak intracellular calcium concentrations in the zona
glomerulosa compared to controls, but the frequency of calcium
spikes did not rise. We conclude that FH-IV, on a molecular level, is
caused by elevated intracellular Ca2+ concentrations as a signal for
aldosterone production in adrenal glomerulosa cells. We demon-
strate that a germline Cacna1h gain-of-function mutation is suffi-
cient to cause mild primary aldosteronism, whereas loss of CaV3.2
channel function can be compensated for in a chronic setting.
CaV3.2 | calcium imaging | adrenal gland
As a key regulator of blood pressure and electrolyte homeo-stasis, the mineralocorticoid hormone aldosterone is syn-
thesized from its precursor cholesterol in the zona glomerulosa
of the adrenal cortex. Cortisol and aldosterone differ by modi-
fication at C-17 in cortisol and C-18 in aldosterone. C-18 mod-
ification is catalyzed by aldosterone synthase (encoded by the
CYP11B2 gene in humans). Altered CYP11B2 expression governs
chronic changes in aldosterone production (1). The two main
physiological stimuli of aldosterone production are volume de-
pletion and elevated blood potassium (hyperkalemia). Volume
depletion activates the renin-angiotensin system (RAS), leading
to production of the peptide hormone angiotensin II (Ang II).
Ang II binds to its selective G protein-coupled receptor in the
zona glomerulosa, triggering calcium release from intracellular
stores, depolarizing cells by inhibition of potassium channels,
and activating voltage-gated calcium influx from the extracellular
space. Hyperkalemia directly depolarizes glomerulosa cells, simi-
larly promoting calcium entry. The resulting elevated intracellular
calcium levels are the key signal for aldosterone production (1, 2).
In response to aldosterone, the kidney increases NaCl reabsorption
and potassium secretion, restoring balance.
When increased production of aldosterone is at least partially
uncoupled from its main physiological stimuli, primary aldoste-
ronism ensues. This disorder is present in about 6% of hypertensives
in a primary care setting and is thus considered the most prevalent
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cause of secondary hypertension (3). Its diagnosis is based on an
elevated aldosterone:renin ratio (ARR) and a positive confir-
matory test, such as the failure to suppress aldosterone levels
upon administration of NaCl (“saline suppression test”) (4). About
one-third of patients with primary aldosteronism have a benign tumor
of the adrenal gland (aldosterone-producing adenoma, APA), and
the majority of the remainder have bilateral adrenal hyperplasia (4).
On a molecular level, about 90% of APAs are explained by hetero-
zygous or hemizygous somatic mutations in one of seven genes (5–7).
Mutations in L-type (CACNA1D) (8, 9) and T-type (CACNA1H)
(10) calcium channel genes directly cause increased calcium influx (8,
11). Mutations in other ion channels [KCNJ5 (12), CLCN2 (13)] and
ion pump genes (ATP1A1, ATP2B3) (14) depolarize the cell mem-
brane and indirectly increase voltage-gated calcium influx. CTNNB1
(15) mutations prevent differentiation of glomerulosa cells into fas-
ciculata cells, leading to increased glomerulosa cell mass (16).
In addition, recent studies suggest that somatic mutations in
APA genes, in particular CACNA1D and ATP1A1, can cause so-
called aldosterone-producing cell clusters, small nodules that pro-
trude into the zona fasciculata and occur in healthy subjects (17)
and, more prominently, in subjects with bilateral adrenal hyper-
plasia (18, 19). Heterozygous mutations in APA genes KCNJ5,
CACNA1D, CACNA1H, and CLCN2 can also occur in the germ-
line, often at the identical positions affected by somatic mutations
(8, 11, 12, 20–22). Such mutations cause an autosomal-dominant
Mendelian disorder called familial hyperaldosteronism (FH).
Additional cases are caused by mutations that create a chimeric
CYP11B1/CYP11B2 gene (23). Patients with FH typically present
with early-onset primary aldosteronism and hypertension. Col-
lectively, these findings characterize primary aldosteronism as a
largely genetic disorder, with somatic mutations in APAs and
bilateral adrenal hyperplasia and germline mutations in FH.
This study focuses on CACNA1H, which we initially described
as a disease gene for FH type IV (FH-IV) (11) in five unrelated
kindreds. All carried the identical Met1549Val mutation. Whereas
the five index cases all presented with hypertension by age 10 y
and showed biochemical evidence of primary aldosteronism, two
of five mutation-carrier relatives were normotensive, suggesting
incomplete penetrance, as occasionally seen in FH (22). In one,
both plasma renin activity and aldosterone levels were normal, in
the other, plasma renin activity was at the lower limit of normal,
and aldosterone was normal. Upon noncurative removal of one
adrenal gland in a clinically affected mutation carrier, microscopic
glomerulosa hyperplasia was observed. Daniil et al. (24) identified
a different de novo mutation at the identical position (Met1549Ile)
in a patient with early-onset primary aldosteronism and multiplex
developmental disorder, along with other variants of less certain
pathogenicity. More recently, Nanba et al. (10) found three ade-
nomas with somatic Ile1430Thr CACNA1H mutations in a cohort
of 75 APAs, establishing them as a rare cause of APAs.
CACNA1H encodes the T-type calcium channel α-subunit CaV3.2.
T-type calcium channels activate at membrane potentials positive
to −70 mV. A steady-state so-called window current occurs at po-
tentials slightly positive to the glomerulosa resting membrane po-
tential at which channels activate, but do not inactivate completely. It
has been suggested that this property, together with oscillations in the
zona glomerulosa membrane potential, allows CaV3.2 to transduce
the calcium current that is necessary for aldosterone production (25).
Like other calcium channel α-subunits, CaV3.2 contains four repeats,
each with six transmembrane segments, and Met1549 mutated in
FH-IV is located in the S6 segment of repeat III. Its mutation causes
loss of normal channel inactivation and a slight shift of activation to
less-depolarizing potentials (11), which in an adrenocortical cancer
cell model is associated with increased aldosterone production (26).
Thus, strong evidence links CACNA1H mutations to primary
aldosteronism. Yet, potential effects of CACNA1H gain-of-function
mutations on adrenal cell mass (11) or on calcium signaling in the
zona glomerulosa have not been studied.
Herein, we generated and characterized a mouse model car-
rying a heterozygous knockin mutation at a position that is ho-
mologous to human Met1549 (Cacna1hM1560V/+). These mice
showed an elevated ARR and elevated systolic and mean arterial
blood pressure as signs of mild primary aldosteronism, but glo-
merulosa histology was normal. Intracellular glomerulosa calcium
concentrations were elevated. We also used a corresponding
knockout model (Cacna1h−/−) to further investigate the physio-
logical role of CaV3.2 in the adrenal gland.
Results
Generation and Characterization of Cacna1hM1560V/+ and Cacna1h−/−
Mice. The protein sequences of the CaV3.2 S6 helix in repeat III,
including the location of the p.Met1549Val mutation in humans,
are completely conserved between human and mouse (11). In ad-
dition, the genomic sequences are identical at the triplet encoding
Met1549 in humans and the corresponding Met1560 (NM_021415.4)
in mice (Fig. 1A). We used CRISPR/Cas9-based genome editing to
introduce the p.Met1560Val mutation on exon 25 of the Cacna1h
gene into the mouse genome (Fig. 1B). Evaluation of different single-
guide RNAs (sgRNAs) by simultaneous injection with Cas9 mRNA
into fertilized eggs, culturing to blastocyst, and genotyping (SI
Appendix, Supplementary Methods) led to the identification of an
sgRNA that caused insertions and deletions in 67% of cultured
embryos. We coinjected this sgRNA with Cas9 mRNA and a donor
oligonucleotide (repair template) and obtained mice carrying the
p.Met1560Val mutation (Cacna1hM1560V/+). One of these mice
carried an 8-bp deletion causing a frameshift and termination codon
(p.His1570Glnfs*83, Cacna1h+/−) in trans. We performed back-
crossing and further bred Cacna1h+/− mice to obtain homozygous
knockout mice (Cacna1h−/−). Both mutant alleles were expressed in
adrenal cDNA (Fig. 1C).
Male and female Cacna1hM1560V/+ and Cacna1h+/− mice were
viable and fertile (SI Appendix, Fig. S1 A–C), and we did not
observe obvious phenotypic abnormalities. However, when
Cacna1h+/− were intercrossed, the number of Cacna1h−/− off-
spring was lower than the number of wild-type (WT) offspring,
pointing to potential reduced fitness of the homozygous knockout
(WT, n = 48, expected: 45; Cacna1h+/−: n = 107, expected: 90 and
Cacna1h−/−: n = 25, expected: 45; P = 0.0021; χ2 test, DF = 2)
(SI Appendix, Fig. S1D), in line with a recent report (27). Con-
stitutively constricted coronary arterioles and focal myocardial
fibrosis have been described in a previously established Cacna1h
knockout model (28, 29). We stained hearts of 48- to 60-wk-old WT,
Cacna1hM1560V/+ and Cacna1h−/− mice with Sirius red to identify
fibrotic areas. While some fibrotic areas were identified, they were
not exclusive to knockout animals (SI Appendix, Fig. S2).
Reduced Survival in Cacna1hM1560V/M1560V Mice.We also intercrossed
Cacna1hM1560V/+ mice. Among 27 resulting litters, 117 mice sur-
vived until weaning and were genotyped. This revealed 40 WT
mice, 76 Cacna1hM1560V/+ mice, and 1 Cacna1hM1560V/M1560V
mouse (SI Appendix, Fig. S1D); the single Cacna1hM1560V/M1560V
mouse died shortly after weaning. The likelihood of seeing one
or fewer Cacna1hM1560V/M1560V mice among 117 offspring by
chance is 9.64 × 10−14 (binomial distribution probability). Next,
we genotyped 25 pups from two additional litters incidentally
found dead shortly after delivery and two litters killed shortly
after birth. Of these neonates, five wereWT, nineCacna1hM1560V/+, and
nine Cacna1hM1560V/M1560V. The discovery of many Cacna1hM1560V/M1560V
mice among neonates together with the unexpectedly low number
of homozygous mice at weaning suggests that Cacna1hM1560V/M1560V
mice succumb to perinatal or early postnatal lethality. We did not
observe obvious external malformations or lower weight in homo-
zygous knockin pups. Because FH-IV is an autosomal-dominant
disorder, we proceeded to characterize heterozygous knockin mice
(Cacna1hM1560V/+).
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Normal Zona Glomerulosa Morphology in Cacna1hM1560V/+ and Cacna1h−/−
Mice. To assess whether Cacna1h mutations cause macroscopic or
microscopic glomerulosa hyperplasia, we harvested adrenal glands
fromCacna1hM1560V/+mice,Cacna1h−/−mice, andWT littermates of
Cacna1hM1560V/+ mice. There was no significant difference in adrenal
weight (Fig. 2A). The presence of the Met1560Val mutation also had
no effect on Cacna1h expression levels by real-time PCR (Fig. 2B),
and subgroup analysis identified no difference in Cacna1h ex-
pression in either male or female mice (Fig. 2C). By in situ hy-
bridization, we identified Cacna1h staining in the zona glomerulosa,
and also the zona fasciculata (SI Appendix, Fig. S3). H&E staining
demonstrated unaltered adrenal zonation in Cacna1hM1560V/+ and
Cacna1h−/− mice compared to WT (Fig. 2 D and E). Next, we
performed in situ hybridization for Cyp11b2 (a marker of zona
glomerulosa) in knockin and knockout mice, as well as controls
(Fig. 3). The fraction of Cyp11b2+ adrenal cells in the adrenal gland
was unchanged in Cacna1hM1560V/+ and Cacna1h−/− mice com-
pared to WT, but the staining intensity per cell was increased in
Cacna1hM1560V/+ mice (SI Appendix, Fig. S4). Cyp11b2 expression
was only detected in the zona glomerulosa, and we did not observe
formation of microscopic Cyp11b2+ nodules. Similarly, adrenal
morphology of Cacna1hM1560V/+ at ages 48 to 60 wk was unaltered
compared to WT (SI Appendix, Fig. S5). Aged Cacna1hM1560V/+mice
frequently showed hydronephrosis (SI Appendix, Fig. S6) [an occa-
sional finding in aged laboratory mice (30), present in five of six
Cacna1hM1560V/+ animals vs. zero of four (nonlittermate)WT animals
and one of five Cacna1h−/− mice, P = 0.011 for Cacna1hM1560V/+
vs. both other genotypes combined, two-tailed Fisher’s exact test].
Cacna1hM1560V/+ Mice Have Elevated Cyp11b2 Expression at Baseline
and upon High-Salt Diet as Well as Elevated ARRs. We next assessed
adrenal Cyp11b2 expression by quantitative real-time PCR (Fig. 4 A–C).
Cacna1hM1560V/+ mice had higher relative Cyp11b2 levels than
WT littermates (1.60 ± 0.98 in Cacna1hM1560V/+ vs. 1.09 ± 0.44 in
controls, mean ± SD throughout Results unless otherwise indicated,
P = 0.004) (Fig. 4A; see legend for statistical tests). Subgroup
analysis demonstrated significantly elevated values in male mice
only (1.78 ± 0.95 in Cacna1hM1560V/+ vs. 1.08 ± 0.43 in controls, P =
0.004) (Fig. 4B). A trend of elevated plasma aldosterone levels in
the overall group was explained by significantly elevated values in
male mice (276.0 ± 108.6 pg/mL in Cacna1hM1560V/+ vs. 200.5 ±
122.7 pg/mL in controls, P = 0.016) (Fig. 4 D and E and Table 1).
To clarify whether aldosterone levels in mutant mice were sus-
ceptible to RAS suppression, we fed mice a 4-wk high-salt diet
(HSD; 1.71% sodium chow, 1% NaCl in drinking water). Cyp11b2
levels were incompletely suppressed in Cacna1hM1560V/+ mice on
HSD compared to controls, suggesting relative autonomy (4.53 ±
3.02 in Cacna1hM1560V/+ vs. 1.23 ± 0.89 in WT littermates, P =
0.008) (Fig. 4C). There was no significant difference in aldosterone
levels (44.4 ± 15.0 pg/mL in Cacna1hM1560V/+ vs. 37.1 ± 19.2 pg/mL
in controls, P = 0.393) (Fig. 4F).
C57BL/6 mice have only one renin gene (Ren1) (31). We mea-
sured renal Ren1 expression levels by quantitative real-time PCR
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Fig. 1. Generation of Cacna1hM1560V/+ and Cacna1h−/− mouse models. (A) Alignment of Mus musculus and Homo sapiens genomic and amino acid sequences
surrounding human Met1549 (box) mutated in FH-IV. Identical nucleotides are shown in yellow. The protein sequence is completely conserved. (B) Repre-
sentation of the mouse Cacna1h locus targeted on exon 25. Sequences of protospacer used to target Cas9 nuclease to exon 25 and repair template used to
introduce Cacna1hM1560V/+ via homology-directed repair are listed below target sequence. The guide binding site is underlined, and intended mutations
(including three silent mutations) are shown in red letters. (C, Upper) Sanger sequences of genomic DNA (gDNA, from ear biopsies) from a WT control, a
Cacna1hM1560V/+ mouse, and a Cacna1h−/− mouse (knockout). (Lower) Sanger sequences of adrenal complementary DNA (cDNA) from the identical animals
shown above, demonstrating adrenal expression of the mutant alleles. Bases adjacent to the 8-bp deletion in Cacna1h−/− are underlined.
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(Fig. 5 A–C). Ren1 expression was not significantly changed in
Cacna1hM1560V/+ mice compared to WT littermates (Fig. 5A),
and subgroup analysis similarly revealed no significant changes in
male and female subgroups (Fig. 5B). Corresponding plasma renin
concentrations (PRCs) were only significantly lower in female
Cacna1hM1560V/+mice compared withWTmice (2,204± 1,008 ng/mL/h
in Cacna1hM1560V/+ vs. 3,290 ± 1,505 ng/mL/h in controls, P =
0.0463) (Fig. 5E), and similar tendencies were seen in males and
in the overall analysis (Fig. 5D).
After HSD, Ren1 expression was not significantly different
between genotypes (Fig. 5C), but Cacna1hM1560V/+ mice had
lower PRCs than WT mice (973 ± 649 ng/mL/h in Cacna1hM1560V/+
vs. 3,734 ± 2,503 ng/mL/h in controls, P = 0.0081) (Fig. 5F).
We calculated a Cyp11b2:Ren1 expression ratio analogous to
the ARR using the respective fold-changes. This ratio was signifi-
cantly elevated in Cacna1hM1560V/+ mice compared to controls both
on a normal-salt diet (NSD; 2.73 ± 3.01 in Cacna1hM1560V/+ vs.
1.22 ± 0.933 in controls, P = 0.005) (Fig. 5G) and on an HSD
(6.48 ± 6.97 in Cacna1hM1560V/+ vs. 1.33 ± 0.747 in controls, P =
0.009) (Fig. 5I). In NSD subgroup analysis, this effect was only
significant in male mice (2.32 ± 1.48 in Cacna1hM1560V/+ vs. 1.23 ±
0.983 in controls, P = 0.01) (Fig. 5H). The corresponding ARR was
similarly elevated both on an NSD (0.250 ± 0.313 pg/mL:ng/mL/h in
Cacna1hM1560V/+ vs. 0.131 ± 0.139 pg/mL:ng/mL/h in controls, P =
0.0326) (Fig. 5J) and on an HSD (0.064 ± 0.039 pg/mL:ng/mL/h in
Cacna1hM1560V/+ versus 0.023 ± 0.021 pg/mL:ng/mL/h in controls,
P = 0.0148) (Fig. 5L). Subgroup analysis of male and female mice
on NSD did not show significant changes even though similar ten-
dencies were seen (Fig. 5K).
Cacna1h−/− Mice Have Normal Adrenal Cyp11b2 and Plasma Aldosterone,
but Elevated Renal Ren1 Levels. Cyp11b2 levels and plasma aldoste-
rone levels were unchanged in Cacna1h−/− mice compared with WT
(Fig. 4 A and D). Whereas renal Ren1 expression was significantly
elevated (1.86 ± 0.86 in Cacna1h−/− versus 1.15 ± 0.59 in WT,
P = 0.026) (Fig. 5A), PRC and ARR did not show significant
changes compared to WT (Fig. 5 D, G, and J).
Cacna1hM1560V/+ Mice Show Normal Plasma and Urinary Electrolytes.
We did not measure significant differences in plasma potassium,
sodium, or chloride levels in Cacna1hM1560V/+ mice compared with
WT (SI Appendix, Fig. S7 A–C). In spot urine, potassium/creatinine
ratio, sodium/creatinine ratio, and chloride/creatinine ratios simi-
larly did not show significant differences (SI Appendix, Fig. S7D–F).
Because aldosterone levels were normal in Cacna1h−/− mice, we did
not assess serum or urinary electrolytes in these animals.
Elevated Blood Pressure in Cacna1hM1560V/+ Mice. We performed
invasive blood pressure monitoring in unanesthetized male mice
by telemetry using carotid artery catheterization and analyzed data
using a linear mixed model approach (Materials and Methods and
Fig. 6). Systolic blood pressure (SBP; P = 0.0010) and mean ar-
terial blood pressure (MAP; P = 0.0017) were elevated by a mean
of 8.3 and 5.4 mmHg, respectively, in male knockin mice com-
pared to WT littermates. Diastolic blood pressure (DBP; P =
0.1394) and heart rate were not significantly changed. Next, we fed
animals an HSD and recorded blood pressure. Similar to the
finding on an NSD, SBP and MAP were significantly elevated in
knockin mice compared with WT controls, whereas DBP and




Fig. 2. Adrenal glands of Cacna1hM1560V/+ and Cacna1h−/− mice show unchanged morphology. (A) Adrenal weight (normalized to body weight) is unchanged
between WT, Cacna1hM1560V/+, and Cacna1h−/− mice (WT: n = 21; M1560V: n = 29; P = 0.69; knockout [KO]: n = 17; P = 0.17; Kruskal–Wallis test with Dunn’s
multiple comparisons test [MCP]). (B) Adrenal expression of Cacna1h is not changed in Cacna1hM1560V/+ compared to WT (M1560V: n = 41; WT: n = 40; P =
0.95; unpaired two-tailed t test of log-transformed fold-change). (C) Cacna1h expression is unchanged between WT and Cacna1hM1560V/+ in both sexes (male
WT: n = 24; male M1560V: n = 17; P > 0.99; female WT: n = 16; female M1560V: n = 24; P > 0.99; Kruskal–Wallis test with Dunn’s MCP of log-transformed fold-
change). All data are shown as box plots (box, interquartile range; whiskers, 1.5 times the interquartile range; line, median; dots, outliers); n values represent
animals. ns, P > 0.05. (D and E) H&E staining of adrenal sections show unaltered morphology of Cacna1hM1560V/+ and Cacna1h−/− mice compared to WT (three
mice each, representative images, pictures of male mice at 15 to 16 wk of age are shown). C, capsule; F, fasciculata; G, glomerulosa; M, medulla. (Scale bars,
500 μm in D and 100 μm in E.).
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Because aldosterone levels were normal in Cacna1h−/− mice, we
did not measure blood pressure in these animals.
Cacna1hM1560V/+ Mice Have Elevated Baseline and Peak Zona Glomerulosa
Calcium Levels.To understand on a cellular level how the Met1560Val
mutation affects calcium signaling in the zona glomerulosa, we
stained adrenal slices of Cacna1hM1560V/+ mice and WT littermate
controls with the fluorescent and cell-permeable calcium indicator
Fura-2 AM (ratiometric, allowing to determine absolute intracellular
calcium concentrations) (SI Appendix, Fig. S8). Individual glomer-
ulosa cells showed spikes of elevated calcium concentrations. These
spikes clustered in bursts of activity, with the calcium concentration
returning to baseline in between bursts (Fig. 7 A and B andMovies
S1 and S2). We determined intracellular calcium concentrations at
baseline (violet in Fig. 7 A and B) and peak (red circles in Fig. 7 A
and B) levels. In the absence of Ang II, spiking was very infre-
quent, precluding statistical analysis of peak values, but baseline
calcium levels were significantly elevated in Cacna1hM1560V/+ mice
at both 3 and 5 mMK+ (Fig. 7C). After addition of Ang II (20 and
1,000 pmol, respectively), spiking increased, and baseline and peak
intracellular calcium levels were significantly elevated in
Cacna1hM1560V/+ mice, again both at 3 and at 5 mM K+ (Fig. 7C).
Similarly, mean overall calcium concentrations (taking into account
concentrations at baseline and during spiking) in Cacna1hM1560V/+
mice were higher than in controls at all conditions tested (3 and
5 mM extracellular K+, each at 0, 20, and 1,000 pM Ang II)
(Fig. 7D). To understand whether the shape of individual spikes
was changed, we used Calbryte 520 AM (nonratiometric, higher
temporal resolution) (SI Appendix, Fig. S9A). The kinetics of the
rise to peak and the fall to baseline calcium concentrations were not
significantly different between Cacna1hM1560V/+ mice and WT mice
(SI Appendix, Fig. S9 B and C).
Finally, the frequency of spiking was slightly lower in Cacna1hM1560V/+
mice at supraphysiologic Ang II levels (1,000 pM) only (Fig. 7E),
likely due to a combination of lower frequencies of spiking during
bursts (SI Appendix, Fig. S10A), decreased burst lengths (SI Ap-
pendix, Fig. S10B), and decreased numbers of bursts (SI Appendix,
Fig. S10C). Values and results of statistical tests for calcium im-
aging are shown in SI Appendix, Table S1. Because Cacna1h is
also expressed in the zona fasciculata (SI Appendix, Fig. S3), we
also investigated 340/385-nm ratios (positively correlating with
the intracellular calcium concentration) in this zone. Intracellular
zona fasciculata calcium levels were higher in Cacna1hM1560V/+
mice than in WT mice (SI Appendix, Fig. S11).
Discussion
Cacna1hM1560V/+ mice develop mild primary aldosteronism, with
approximately twofold elevated ARRs compared to WT (Fig. 5
and Table 1) and an increase in systolic blood pressure of 8
mmHg (Fig. 6), but without significant effects on serum or urinary
electrolytes (although changes may be more easily detected in
24-h urine than in spot urine) (SI Appendix, Fig. S7). We observed
a similar, smaller trend (though not significant) for DBP, which is
interesting because primary aldosteronism in humans can be as-
sociated with isolated systolic hypertension (32). The moderate
elevation of blood pressure may explain why only a trend of lower
PRC levels was observed (Fig. 5 and Table 1). In addition, PRC
levels can be artificially high due to stress-induced secretion and
hypovolemia as a result of blood collection. Unexpectedly high
PRC levels in WT animals on an HSD (Fig. 5F) may be due to
such confounders. Of note, Ren1 expression is less affected by
such acute stimuli (33).
Blood pressure elevation in the range we observed in knockin
animals (8.3 mmHg systolic) is clinically significant; lowering
SBP by 10 mmHg has been associated with an ∼40% lower risk of
death from stroke and 30% lower risk from ischemic heart or other
vascular disease in humans (34). Contrary to a model with increased
expression of aldosterone synthase (35), Cacna1hM1560V/+ mice did
not show salt sensitivity of blood pressure. The underlying reasons
remain to be clarified.
The phenotype in our model is milder than that of human
index cases (11). Importantly, due to selection bias, human index
cases likely represent phenotypic extremes. Mutation-carrier family
members are better representatives of the phenotypic disease
spectrum than index cases. The absence of hypertension and bio-
chemical evidence of primary aldosteronism in two of five mutation-
carrier family members (see introduction) suggests a rather mild
phenotype in humans, similar to that of the mouse model described
here. The severe phenotype in some patients raises the question
whether factors other than the germline mutation could play a role
in determining disease severity. Interestingly, the single patient who
underwent adrenalectomy and for whom histology was available
showed microscopic glomerulosa hyperplasia with nodular invasion
of the capsule (11), unlike the mice characterized here. Such hy-
perplasia may be due to additional somatic mutations, as in recently
described aldosterone-producing cell clusters (17), and could con-
tribute to more severe primary aldosteronism and hypertension in
some patients. Conversely, previously unexplained incomplete
penetrance (11) may be related to the absence of hyperplasia in
other subjects.
Overall adrenal Cyp11b2 expression (by quantitative real-time
PCR) was elevated in our mouse model, yet the fraction of Cyp11b2+
cells in Cacna1hM1560V/+ mice (by in situ hybridization) was normal
(SI Appendix, Fig. S4A), and no histologic changes were observed,
suggesting that individual glomerulosa cells express higher amounts
of Cyp11b2. Accordingly, staining intensity per cell (by in situ hy-
bridization) was increased in Cacna1hM1560V/+ mice (SI Appendix,
Fig. S4B), although this observation is qualitative due to signal
amplification during staining (36).
As in another model of primary aldosteronism with Clcn2
gain-of-function mutation (37), changes in aldosterone were more
pronounced in male than in female animals, possibly due to sex
dimorphism in adrenocortical tissue renewal or changes during the
estrus cycle that cause higher variability in female mice (38, 39).
Contrary to Cyp11b2 levels, in the overall group, aldosterone was
not significantly elevated, although a trend was seen (Fig. 4D). A

























































Fig. 3. Adrenal sections of Cacna1hM1560V/+ and Cacna1h−/− mice show
normal Cyp11b2 staining. (A and B) In situ hybridization with corresponding
negative controls (see Materials and Methods). One of four to five animals
of each genotype is shown. C: capsule; F: fasciculata; G, glomerulosa; M:
medulla. (Scale bars, 500 μm in A and 100 μm in B.)
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to renin measurements, see Discussion above) is the stress caused
by the handling of animals prior to the blood draw, which can
trigger aldosterone release (40).
Whether mice homozygous for the M1560V allele have more
severe primary aldosteronism than heterozygous mice, as ob-
served in a mouse model with N-terminal Clcn2 deletion (41),
could not be investigated due to apparent early lethality of ho-
mozygous mice. While the cause of lethality was not be established
in this study, it would be interesting to assess whether homozygous
Cacna1h knockin mice have evidence of severe hypertension at
birth, which might, for example, manifest as cardiac hypertrophy.
In heterozygous knockin mice, we did not detect target-organ damage
(hypertensive nephropathy or cardiac abnormalities). Hydronephrosis
may be a chance finding as it frequently occurs in aged mice (andWT
controls of aged mice were not littermates). However, we note that
CaV3.2 has been implicated in renal pacemaker activity, which trig-
gers upper urinary tract peristalsis, moving urine from the kidney to
the bladder (42).
T-type calcium channels are both activated and inactivated by
voltage. The fraction of activated channels rises with increasing
voltage in a sigmoidal fashion. In parallel, the fraction of chan-
nels that are not inactivated decreases in a sigmoidal fashion.
The small voltage “window” in which these curves overlap allows
for a small constitutive, noninactivating “window current” (see
introduction). In channels with the Met1549Val mutation (in the
human ortholog), we previously demonstrated by electrophysiology
that channel activation occurs at more negative membrane po-
tentials (closer to the resting membrane potential of glomerulosa
cells). As a result, the window current is larger than in WT channels
(11). This larger constitutive current explains higher intracellular
baseline glomerulosa calcium levels in Cacna1hM1560V/+ mice
(Fig. 7 C and D). In addition, impaired channel inactivation could
lead to increased calcium influx at more depolarized potentials
(i.e., during peaks). Interestingly, the spiking frequency was not
elevated in Cacna1hM1560V/+ mice, and even lower than in controls
under some conditions (Fig. 7E and SI Appendix, Fig. S10A).
These findings are consistent with prior data suggesting that
CaV3.2 is not the pacemaker in the depolarization phase of the
oscillatory cycle. CaV3.2 current remains relatively constant and
small in the interspike interval (25) (accounting for stably elevated
baseline calcium levels in the mutant, see Discussion above). The
initial depolarization that triggers rapid calcium influx during
spikes must therefore be mediated by channels other than CaV3.2.
Accordingly, a Clcn2 gain-of-function mutation, which indirectly
raises intracellular calcium via depolarization of glomerulosa
cells, causes increased calcium spiking frequencies (37, 41). Lower
frequencies under supraphysiological stimulation could be accoun-
ted for by two effects. First, recovery from inactivation is slower in
channels carrying the Met1549Val mutation (11), and channels may
take longer to be “available” for the next spike. Second, higher
calcium levels in the presence of mutant channels could activate






















































































































































































































Fig. 4. Cacna1hM1560V/+ mice have elevated adrenal Cyp11b2 expression. (A) Adrenal Cyp11b2 expression is increased in Cacna1hM1560V/+ mice during NSD
(WT: n = 43; Cacna1hM1560V/+: n = 43; P = 0.004 vs. WT; KO: n = 11; P = 0.996 vs. WT; one-way ANOVA with Dunnett’s MCP). (B) Cyp11b2 expression is only
increased in male Cacna1hM1560V/+ mice (male WT: n = 24; male Cacna1hM1560V/+: n = 18; P = 0.004; female WT: n = 19; female Cacna1hM1560V/+: n = 25; P =
0.294; one-way ANOVA and Sidak’s MCP). (C) Adrenal Cyp11b2 expression remains elevated in Cacna1hM1560V/+ mice during HSD (WT: n = 12; Cacna1hM1560V/+:
n = 9; P = 0.008; unpaired two-tailed t test). (D) Plasma aldosterone is not significantly changed in Cacna1hM1560V/+ mice or Cacna1h−/− mice during NSD (WT:
n = 42; Cacna1hM1560V/+: n = 41; P = 0.090; KO: n = 13; P = 0.895; Kruskal–Wallis test and Dunn’s MCP). (E) Plasma aldosterone is significantly increased in male,
but not in female Cacna1hM1560V/+ mice (male WT: n = 23; male Cacna1hM1560V/+: n = 17; P = 0.016; female WT: n = 19; female Cacna1hM1560V/+: n = 24; P >
0.999; Kruskal–Wallis test and Dunn’s MCP). (F) There is no significant difference in aldosterone between Cacna1hM1560V/+ and WT during HSD (WT: n = 8;
Cacna1hM1560V/+: n = 9; P = 0.393; unpaired two-tailed t test). Box plots (box, interquartile range; whiskers, 1.5 times the interquartile range; line, median;
dots, outliers) are shown in the figure; n values are animals. ns, P > 0.05; *P < 0.05; **P < 0.01.
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such channels would then hyperpolarize the cell and delay the
next spike. Future pharmacologic studies could be instrumental
to further investigate this effect. In any case, increased baseline
and peak calcium levels result in a net increase in overall mean
intracellular calcium levels (Fig. 7D), explaining the pathophys-
iology of FH-IV. Interestingly, intracellular calcium levels are
elevated not only in the zona glomerulosa, but also the zona fas-
ciculata of Cacna1hM1560V/+ mice (SI Appendix, Fig. S11). While
calcium may play a potentiating role, cAMP, downstream of ACTH,
is the main stimulus of glucocorticoid production in the zona fas-
ciculata (44). Given the rather mild effects of the Met1549Val mu-
tation on aldosterone production, a major effect on glucocorticoid
production appears unlikely, but was not investigated in this study.
Hypercortisolism has not been reported in humans with FH-IV.
Detailed studies were performed in one of the five index cases in the
original description, demonstrating normal 24-h urinary free cortisol
and normal ACTH (11).
Of further interest is the Cacna1h−/− mouse model. CaV3.2
has been proposed to be essential for intrinsic voltage oscillatory
activity in the zona glomerulosa (25), raising the question whether
inhibition of CaV3.2 could be a useful mechanism to lower blood
pressure or aldosterone levels in the general population. Prior
studies of another Cacna1h−/− model argue against such an effect,
with normal aldosterone and renin levels and normal blood
pressure (45). Similarly, Mibefradil, a calcium channel inhibitor
that preferentially blocks T-type channels [withdrawn from the
market (46)] does not have lasting effects on blood pressure or
aldosterone levels (11, 47, 48) despite inhibitory effects in vitro
(49). Our observations that Cyp11b2 expression and aldosterone
levels are not significantly changed in Cacna1h−/− mice (Fig. 4 A
and D) support these prior findings and suggest that CaV3.2 is
dispensable for aldosterone production in the zona glomerulosa
in a chronic setting; elevated Ren1 expression may suggest some
degree of RAS activation. Thus, CaV3.2 inhibitors could possibly
be used to treat patients with gain-of-function CACNA1H mu-
tations (26), but are likely less suitable as a monotherapy for
hypertension in the general population.
In summary, we have generated and characterized a mouse
model of FH-IV, with mild primary aldosteronism. We show that
primary aldosteronism in this model is due to higher baseline and
peak intracellular calcium levels in the zona glomerulosa, caused
by gain of CaV3.2 channel function. In a chronic setting, normal
CaV3.2 appears to be dispensable for aldosterone production,
perhaps because of compensatory mechanisms. It will be inter-
esting to study in more detail the voltage and calcium oscillatory
activity in the zona glomerulosa of Cacna1h−/− mice and char-
acterize alternative calcium entry pathways.
Materials and Methods
Detailed methods are available in SI Appendix.
Generation of the Cacna1hM1560V/+ Mouse Model. CRISPR/Cas-mediated muta-
tion of Cacna1h Met1560 to Val was performed at the Yale Genome Editing
Center, essentially as described previously (50).
Animals and Sample Collection. Mice were bred and housed at the For-
schungseinrichtungen für Experimentelle Medizin (Charité - Universitätsmedizin
Berlin). They were maintained under specific-pathogen free conditions in a 12-h
light/dark cycle with ad libitum access to food and water. All animal experiments
were approved by the local authorities (Landesamt für Gesundheit und Soziales
Berlin) and performed under consideration of all relevant ethical regulations.
Blood, tissue, and urine were collected as previously described (37).
Quantitative Real-Time PCR. Isolation of total RNA from adrenal glands and
kidneyswas done using themiRNeasyMini Kit (Qiagen). Nanodrop 2000 (Thermo
Scientific) was used for assessment of concentration and purity, and reverse
transcriptionwas done using Quantitect RT Kit (Qiagen). In adrenal cDNA,Gapdh
(Mm99999915_g1, housekeeping gene) and Cyp11b2 (Mm00515624_m1) were
amplified using Taqman Gene Expression Master Mix (Applied Biosystems).
Gapdh (primers 5′-TGTAGACCATGTAGTTGAGGTCA-3′ and 5′-AGGTCGGTGTGA-
ACGGATTTG-3′), Ren1 (5′-TCTGGGCACTCTTGTTGCTC-3′ and 5′-GGGGGAGGT-
AAGATTGGTCAA-3′), and Cacna1h (5′-CGGCCCTACTACGCAGACTA-3′ and 5′-
CCAGAGACTTGGGCTGGTTG-3′) were amplified from kidney and adrenal cDNA,
respectively, using Power SYBR Green PCR Master Mix (Applied Biosystems).
Gene expression was evaluated relative to Gapdh and mean ΔCT of WT controls
and expressed as 2ΔΔCt (fold-change).
H&E and Sirius Red Staining. H&E and Sirius red staining of formalin-fixed,
paraffin-embedded (FFPE) adrenal glands, kidneys, and hearts was done as
previously described (37).
In Situ Hybridization. Cyp11b2 in situ hybridization was performed on 5-μm
FFPE adrenal gland sections using the RNAscope 2.5 HD Assay-Brown
(Advanced Cell Diagnostics) according to the manufacturer’s instructions
(document numbers: 322452 and 322310-USM). Probes were Mm-Cyp11b2
(Cat No. 505851), and DapB (Cat No. 310043, negative control).
Table 1. Characteristics of WT, Cacna1hM1560V/+, and Cacna1h−/− mice





















































































































M1560V, Cacna1hM1560V/+; KO, Cacna1h−/−; Crea, creatinine. All values on normal-salt diet. *P < 0.05 versus corresponding WT. All values given as mean ±
SD. N/A, not available.
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Fig. 5. Cacna1h−/− mice show elevated Ren1 expression; Cacna1hM1560V/+ mice have elevated ARRs. (A–C) Kidney expression of Ren1 is increased in KO mice
but not significantly changed in Cacna1hM1560V/+ mice during NSD (WT: n = 43; Cacna1hM1560V/+: n = 43; P = 0.095 vs. WT; KO: n = 11; P = 0.026 vs. WT; one-way
ANOVA and Dunnett’s MCP; male WT: n = 24; male Cacna1hM1560V/+: n = 18; P = 0.688; female WT: n = 19; female Cacna1hM1560V/+: n = 25; P = 0.078; one-way
ANOVA and Sidak’s MCP) or HSD (WT: n = 12; Cacna1hM1560V/+: n = 9; P = 0.425; Mann–Whitney test). (D–F) PRC is not significantly changed in Cacna1hM1560V/+
and Cacna1h−/− mice during NSD (WT: n = 39; Cacna1hM1560V/+: n = 40; P = 0.115; KO: n = 13; P > 0.999; Kruskal–Wallis test and Dunn’s MCP). In subgroup
analysis, PRC is decreased in female Cacna1hM1560V/+ mice only (male WT: n = 22; male Cacna1hM1560V/+: n = 17; P = 0.821; female WT: n = 17; female
Cacna1hM1560V/+: n = 23; P = 0.046; Kruskal–Wallis test and Dunn’s MCP). PRC is reduced in Cacna1hM1560V/+ mice during HSD (WT: n = 10; Cacna1hM1560V/+: n =
8; P = 0.008; unpaired two-tailed t test). (G–I) The ratio of Cyp11b2 and Ren1 expression was calculated using fold-change. (G) Expression ratio is significantly
increased in Cacna1hM1560V/+ compared to WT mice and not significantly changed in Cacna1h−/− compared to WT (WT: n = 43; M1560V: n = 43; P = 0.005;
Cacna1h−/−: n = 11, P = 0.176; Kruskal–Wallis test, Dunn’s MCP). (H) The ratio is significantly increased in male Cacna1hM1560V/+ mice compared to WT (WT: n =
24; Cacna1hM1560V/+: n = 18; P = 0.010; Kruskal–Wallis test and Dunn’s MCP), but not in female mice (WT: n = 19; Cacna1hM1560V/+: n = 25; P = 0.074;
Kruskal–Wallis test and Dunn’s MCP). (I) After HSD, the ratio is significantly increased in Cacna1hM1560V/+ mice compared to WT (WT: n = 12; Cacna1hM1560V/+:
n = 9; P = 0.009; Mann–Whitney test). (J) ARRs (calculated using plasma aldosterone levels and PRC) are increased in Cacna1hM1560V/+ mice compared to WT
under NSD (WT: n = 39; M1560V: n = 39; P = 0.033; Kruskal–Wallis test with Dunn’s MCP). In Cacna1h−/− mice, ARR is not significantly changed compared to
WT (WT: n = 39; KO: n = 13; P = 0.540; Kruskal–Wallis test, Dunn’s MCP). (K) ARR levels are not significantly changed in subgroup analyses (male WT: n = 22;
M1560V: n = 17; P = 0.070; female mice WT: n = 17; M1560V: n = 22; P = 0.353; Kruskal–Wallis test, Dunn’s MCP). (L) After HSD, ARR remains elevated in
Cacna1hM1560V/+ mice (WT: n = 8; Cacna1hM1560V/+: n = 8; P = 0.015; unpaired two-tailed t test). All data are shown in box plots (box, interquartile range;
whiskers, 1.5 times the interquartile range; line, median; dots, outliers); n values are animals. ns, P > 0.05; *P < 0.05; **P < 0.01.
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Microscopy. Pictures of adrenal glands (H&E staining and in situ hybridization)
and hearts (Sirius red staining) were recorded with an Axioplan 2 microscope
equippedwith a Hal100microscope lamp and anAxiocamMRc5 camera using
Plan-Neofluar (5×, 10×, 40×) objectives and Axiovision Rel 4.8 software (all
from Carl Zeiss). Pictures of whole kidneys (H&E staining) were recorded
with an Axioscop 40 equipped with an Axiocam MRc5 and MCX-2eco high-
resolution position controller using a Plan-Apochromat 20× objective and
Axiovision Rel 4.8 software (all from Carl Zeiss).
Aldosterone ELISA. Plasma aldosterone concentration (pg/mL) was measured
by enzyme-linked immunosorbent assay (ELISA, RE52301; IBL International)
according to the manufacturer’s instructions.
Determination of PRC. PRC was determined by measuring the capability of the
sample to generate angiotensin I (AT-I) from excess renin substrate, as
previously described (51).
Determination of Electrolytes. Plasma and urine electrolytes (K+, Na+, Cl−) and
urine creatinine were measured using an AU480 Clinical Chemistry Analyzer
(Beckman Coulter) at the Animal Phenotyping Facility at Max-Delbrück-
Centrum Berlin. Urine electrolyte concentrations were normalized to urine
creatinine.
Blood Pressure Measurements. Blood pressure was measured via telemetry, as
previously described (37).
Calcium Imaging. For slice preparation, adrenal glands were rapidly extracted
from 12- to 18-wk-old mice (WT: 7 female and 9male; M1560V: 10 female and 7
male mice) following anesthesia with isoflurane (1 mL as open drop) and cer-
vical dislocation. The glands were then transferred into ice-cold bicarbonate-
buffered saline (BBS: 119 mmol/L NaCl, 2 mmol/L KCl, 26 mmol/L NaHCO3, 0.1
mmol/L CaCl2, 5 mmol/L MgCl2, 10 mmol/L glucose) gassed with carbogen (95%
O2 + 5% CO2).
After removal of surrounding fat, both glands were embedded into 3%
low-melting temperature agarose in BBS and glued to the mounting stage
of a vibratome (7,000 smz-2; Campden Instruments). Organs in the agarose
block were maintained in gassed BBS at temperatures below 4 °C at all
times. Slices were cut at 70-μm thickness and transferred to BBS at 35 °C for
30 min for regeneration. Afterward, adrenal slices were stored for up to 6 h
in BBS supplemented with 2 mmol/L CaCl2 at room temperature (∼22 °C).
Slice staining of adrenal slices was performed in a cell culture insert within
a single well of a 24-well plate. The well was filled with 750 μL of BBS and the
insert with 250 μL containing initially 64 μmol/L Fura-2 AM + 10% Pluronic F-
127 dissolved in BBS. The well was continuously gassed with carbogen. Slices
were left in the staining solution for 1 h followed by 15 min of de-
esterification in BBS without Fura-2.
For recording, slices were placed in a recording chamber continuously
perfused with solution from a reservoir supplied with carbogen gas. Two
solutions were prepared and mixed to yield the potassium concentration of
interest (BBS 2K+ : 119 mmol/L NaCl, 2 mmol/L KCl, 26 mmol/L NaHCO3, 5
mmol/L NaGluconate, 2 mmol/L CaCl2, 1 mmol/L MgCl2, 10 mmol/L glucose;
and BBS 7K+: 119 mmol/L NaCl, 2 mmol/L KCl, 26 mmol/L NaHCO3, 5 mmol/L
KGluconate, 2 mmol/L CaCl2, 1 mmol/L MgCl2, 10 mmol/L glucose). Ang II was
added from a 1 mmol/L stock to the final concentration as indicated. Fura-2
fluorescence was alternately excited at 340 and 385 nm using a FuraLED
light source (Cairn Research). Images were taken every 100 ms with 10-ms
exposure using an OptiMOS camera (QImaging).
Statistics. Data were analyzed using GraphPad Prism 8 unless otherwise
indicated.
Data Availability. Calcium imaging data and analysis scripts are available at
https://doi.org/10.5281/zenodo.4671006 (52). Blood pressure data and code
are available at http://doi.org/10.5281/zenodo.4672114 (53).
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Fig. 6. Blood pressure is higher in Cacna1hM1560V/+ mice. Blood pressure (BP) and heart rate (HR) of animals were assessed during NSD and HSD through
common carotid artery telemetry. Graphs show loess regressions of BP or HR of WT (black, n = 8 animals on NSD and n = 7 on HSD) and Cacna1hM1560V/+ (red,
n = 7 animals for both conditions) mice. Gray intervals denote 95% confidence intervals for loess regressions. Horizontal axis shows time, with black lines
noting nights (6:00 PM to 6:00 AM). Horizontal lines show means for the entire NSD and HSD period, respectively, for WT (black) and Cacna1hM1560V/+ (red
dashed) animals. Nested-model likelihood ratio comparisons revealed significantly higher SBP (P = 0.001) and MAP (P = 0.002) during NSD; DBP (P = 0.139) and
HR (P = 0.135) were not significantly changed. n = 9 WT, n = 8 Cacna1hM1560V/+ animals. Mean ± SD values: NSD-SBP, 115.9 ± 13.7 mmHg (WT), 124.2 ± 14.7
mmHg (Cacna1hM1560V/+); NSD-DBP, 85.0 ± 12.1 mmHg (WT) and 87.7 ± 11.9 mmHg (Cacna1hM1560V/+); NSD-MAP, 99.9 ± 12.5 mmHg (WT) and 105.2 ± 13.1
mmHg (Cacna1hM1560V/+); NSD-HR, 462.2 ± 100.4 beats per minute (BPM, WT) and 482.1 ± 111.1 BPM (Cacna1hM1560V/+). Similarly, during HSD, SBP (P = 0.0008)
and MAP (P = 0.021) were increased in Cacna1hM1560V/+ mice, while DBP (P = 0.65) and HR (P = 0.92) were unchanged. One WT mouse failed HSD recording.
Mean ± SD: HSD-SBP, 122.2 ± 15.7 mmHg (WT) and 128.8 ± 18.1 mmHg (Cacna1hM1560V/+); HSD-DBP, 88.2 ± 13.4 mmHg (WT) and 89.2 ± 13.7 mmHg
(Cacna1hM1560V/+); HSD-MAP, 104.5 ± 14.2 mmHg (WT) and 108.0 ± 15.4 mmHg (Cacna1hM1560V/+); HSD-HR, 450.9 ± 92.3 BPM (WT) and 451.8 ± 100.9 BPM
(Cacna1hM1560V/+).
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Fig. 7. Cacna1hM1560V/+ mice have higher intracellular calcium concentrations than controls. (A and B) Representative average projections over 20 s from a
WT or M1560V adrenal slice stained with Fura-2 AM (Upper). Intensity corresponds to the intracellular calcium concentration. (Scale bars, 10 μm.) The
concentration changes of one representative cell each (both at 5 mM K+ and 1 nM Ang II) are shown below. The trace is color-coded to represent baseline
concentrations (purple), spiking activity (black) and peak concentrations (center of red circles). (C) Baseline as well as peak intracellular calcium concentrations
are higher in Cacna1hM1560V/+ compared to WT mice under all tested conditions. (D) The mean overall intracellular calcium concentrations (including baseline,
spiking and peak segments) are also elevated in Cacna1hM1560V/+ mice. (E) Mean frequencies of calcium spikes during the corresponding perfusions are lower
in Cacna1hM1560V/+ than in WT mice at supraphysiological concentrations of Ang II only. P values (likelihood ratio test of linear mixed models) are indicated as
follows: ns, P ≥ 0.05; *P < 0.05; **P < 0.01; ***P < 0.001. See SI Appendix, Table S1 for statistical information. Data in C and D are shown as bars (mean) ± SD.
Data in E are shown in box plots (box, interquartile range; whiskers, 1.5 times the interquartile range; line, median; dots, outliers).
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